Advancement of NF-κB Signaling Pathway: A Novel Target in Pancreatic Cancer

Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers and is the third highest among cancer related deaths. Despite modest success with therapy such as gemcitabine, pancreatic cancer incidence remains virtually unchanged in the past 25 years. Among the several driver mutations for...

Descripción completa

Detalles Bibliográficos
Autores principales: Pramanik, Kartick C., Makena, Monish Ram, Bhowmick, Kuntal, Pandey, Manoj K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320793/
https://www.ncbi.nlm.nih.gov/pubmed/30563089
http://dx.doi.org/10.3390/ijms19123890

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320793/
https://www.ncbi.nlm.nih.gov/pubmed/30563089
http://dx.doi.org/10.3390/ijms19123890

Ejemplares similares